• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚砷酸盐和镉通过膜雌激素受体和G蛋白偶联雌激素受体信号通路激活人肺腺癌细胞中的MAPK/ERK。

Arsenite and Cadmium Activate MAPK/ERK via Membrane Estrogen Receptors and G-Protein Coupled Estrogen Receptor Signaling in Human Lung Adenocarcinoma Cells.

作者信息

Huff Mary O, Todd Sarah L, Smith Aaron L, Elpers Julie T, Smith Alexander P, Murphy Robert D, Bleser-Shartzer Allison S, Hoerter Jacob E, Radde Brandie N, Klinge Carolyn M

机构信息

*Department of Biology, Bellarmine University, Louisville, Kentucky 40205;

†Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky 40292.

出版信息

Toxicol Sci. 2016 Jul;152(1):62-71. doi: 10.1093/toxsci/kfw064. Epub 2016 Apr 12.

DOI:10.1093/toxsci/kfw064
PMID:27071941
Abstract

Epidemiological evidence indicates that cadmium and arsenic exposure increase lung cancer risk. Cadmium and arsenic are environmental contaminants that act as endocrine disruptors (EDs) by activating estrogen receptors (ERs) in breast and other cancer cell lines but their activity as EDs in lung cancer is untested. Here, we examined the effect of cadmium chloride (CdCl2) and sodium arsenite (NaAsO2) on the proliferation of human lung adenocarcinoma cell lines. Results demonstrated that both CdCl2 and NaAsO2 stimulated cell proliferation at environmentally relevant nM concentrations in a similar manner to 17β-estradiol (E2) in H1793, H2073, and H1944 cells but not in H1792 or H1299 cells. Further studies in H1793 cells showed that 100 nM CdCl2 and NaAsO2 rapidly stimulated mitogen-activated protein kinase (MAPK, extracellular-signal-regulated kinases) phosphorylation with a peak detected at 15 min. Inhibitor studies suggest that rapid MAPK phosphorylation by NaAsO2, CdCl2, and E2 involves ER, Src, epidermal growth factor receptor, and G-protein coupled ER (GPER) in a pertussis toxin-sensitive pathway. CdCl2 and E2 activation of MAPK may also involve ERβ. This study supports the involvement of membrane ER and GPER signaling in mediating cellular responses to environmentally relevant nM concentrations of CdCl2 and NaAsO2 in lung adenocarcinoma cells.

摘要

流行病学证据表明,接触镉和砷会增加患肺癌的风险。镉和砷是环境污染物,可通过激活乳腺癌和其他癌细胞系中的雌激素受体(ERs)来充当内分泌干扰物(EDs),但它们在肺癌中作为EDs的活性尚未得到测试。在此,我们研究了氯化镉(CdCl2)和亚砷酸钠(NaAsO2)对人肺腺癌细胞系增殖的影响。结果表明,在环境相关的纳摩尔浓度下,CdCl2和NaAsO2均以与17β-雌二醇(E2)相似的方式刺激H1793、H2073和H1944细胞的增殖,但对H1792或H1299细胞无此作用。对H1793细胞的进一步研究表明,100 nM CdCl2和NaAsO2能迅速刺激丝裂原活化蛋白激酶(MAPK,细胞外信号调节激酶)磷酸化,在15分钟时检测到峰值。抑制剂研究表明,NaAsO2、CdCl2和E2对MAPK的快速磷酸化作用涉及ER、Src、表皮生长因子受体和G蛋白偶联ER(GPER),且通过百日咳毒素敏感途径发挥作用。CdCl2和E2对MAPK的激活作用可能也涉及ERβ。本研究支持膜ER和GPER信号传导参与介导肺腺癌细胞对环境相关纳摩尔浓度的CdCl2和NaAsO2的细胞反应。

相似文献

1
Arsenite and Cadmium Activate MAPK/ERK via Membrane Estrogen Receptors and G-Protein Coupled Estrogen Receptor Signaling in Human Lung Adenocarcinoma Cells.亚砷酸盐和镉通过膜雌激素受体和G蛋白偶联雌激素受体信号通路激活人肺腺癌细胞中的MAPK/ERK。
Toxicol Sci. 2016 Jul;152(1):62-71. doi: 10.1093/toxsci/kfw064. Epub 2016 Apr 12.
2
Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells.亚砷酸钠抑制基因组雌激素信号传导,但通过丝裂原活化蛋白激酶(MAPK)途径在乳腺癌细胞中诱导磷酸化雌激素受体α(Ser118)。
Environ Toxicol. 2016 Sep;31(9):1133-46. doi: 10.1002/tox.22122. Epub 2015 Mar 2.
3
Role of aromatase activation on sodium arsenite-induced proliferation, migration, and invasion of MDA-MB-231 and MDA-MB-453 breast cancer cell lines.芳香酶激活在亚砷酸钠诱导 MDA-MB-231 和 MDA-MB-453 乳腺癌细胞系增殖、迁移和侵袭中的作用。
Toxicology. 2020 May 15;437:152440. doi: 10.1016/j.tox.2020.152440. Epub 2020 Mar 18.
4
Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK pathway in human breast cancer MCF-7 cells.雌激素受体α(ERα)以及表皮生长因子受体(EGFR)和Src激酶的基础活性在镉诱导的人乳腺癌MCF-7细胞丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)信号通路激活中的作用
Toxicol Appl Pharmacol. 2015 Aug 15;287(1):26-34. doi: 10.1016/j.taap.2015.05.010. Epub 2015 May 23.
5
Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells.通过 G 蛋白偶联受体 30 和雌激素受体 α/β 介导低剂量双酚 A 激活 ERK1/2 促进 TM4 细胞生长。
Toxicol Lett. 2014 Apr 7;226(1):81-9. doi: 10.1016/j.toxlet.2014.01.035. Epub 2014 Feb 2.
6
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.G蛋白偶联雌激素受体(GPER)介导17β-雌二醇(E2)和选择性激动剂G1诱导的非小细胞肺癌进展。
Med Oncol. 2015 Apr;32(4):104. doi: 10.1007/s12032-015-0558-2. Epub 2015 Mar 6.
7
17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.吉非替尼治疗后,通过降低GPER表达可阻止17β-雌二醇诱导的三阴性乳腺癌细胞生长。
Oncol Rep. 2017 Feb;37(2):1212-1218. doi: 10.3892/or.2016.5306. Epub 2016 Dec 8.
8
Cadmium at nanomolar concentrations activates Raf-MEK-ERK1/2 MAPKs signaling via EGFR in human cancer cell lines.纳摩尔浓度的镉通过表皮生长因子受体(EGFR)激活人类癌细胞系中的Raf-MEK-ERK1/2丝裂原活化蛋白激酶(MAPKs)信号通路。
Chem Biol Interact. 2015 Apr 25;231:44-52. doi: 10.1016/j.cbi.2015.02.014. Epub 2015 Mar 2.
9
[Influence of pertussis toxin on GPER-mediated activation of phosphatidylinositol 3-kinase/protein kinase B signaling induced by 17β-estradiol in endometrial carcinoma cells].[百日咳毒素对17β-雌二醇诱导的子宫内膜癌细胞中G蛋白偶联雌激素受体介导的磷脂酰肌醇3激酶/蛋白激酶B信号通路激活的影响]
Zhonghua Fu Chan Ke Za Zhi. 2013 Feb;48(2):129-33.
10
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.雌激素诱导的Erk-1和Erk-2激活需要G蛋白偶联受体同系物GPR30,并通过释放HB-EGF对表皮生长因子受体进行反式激活而发生。
Mol Endocrinol. 2000 Oct;14(10):1649-60. doi: 10.1210/mend.14.10.0532.

引用本文的文献

1
Characteristics of genomic alterations and heavy metals in hypertensive patients with non‑small cell lung cancer.非小细胞肺癌高血压患者的基因组改变和重金属特征
Oncol Lett. 2025 Jan 22;29(3):152. doi: 10.3892/ol.2025.14898. eCollection 2025 Mar.
2
TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway.TFAP2A通过促进ESR2介导的MAPK信号通路,驱动非小细胞肺癌(NSCLC)进展并导致对靶向治疗耐药。
Cell Death Discov. 2024 Dec 18;10(1):491. doi: 10.1038/s41420-024-02251-5.
3
Differences in Genomic Alterations and Accumulations of Heavy Metals Between Advanced Non-small Cell Lung Cancer Patients with and without Bone Metastasis.
伴有和不伴有骨转移的晚期非小细胞肺癌患者之间的基因组改变和重金属蓄积差异
J Cancer. 2024 Jun 3;15(13):4205-4218. doi: 10.7150/jca.95191. eCollection 2024.
4
Mechanisms of Heavy Metal Cadmium (Cd)-Induced Malignancy.重金属镉(Cd)诱导恶性肿瘤的机制。
Biol Trace Elem Res. 2025 Feb;203(2):608-623. doi: 10.1007/s12011-024-04189-2. Epub 2024 Apr 29.
5
The Relationship between Cadmium Exposure and Mortality in Postmenopausal Females: A Cohort Study of 2001-2018 NHANES.镉暴露与绝经后女性死亡率的关系:2001-2018 年 NHANES 的队列研究。
Nutrients. 2023 Oct 30;15(21):4604. doi: 10.3390/nu15214604.
6
Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes.不同组织学亚型非小细胞肺癌中基因组改变和重金属的差异。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9999-10013. doi: 10.1007/s00432-023-04929-2. Epub 2023 May 31.
7
Comparative G-Protein-Coupled Estrogen Receptor (GPER) Systems in Diabetic and Cancer Conditions: A Review.糖尿病和癌症条件下比较 G 蛋白偶联雌激素受体(GPER)系统:综述。
Molecules. 2022 Dec 15;27(24):8943. doi: 10.3390/molecules27248943.
8
Implications of estrogen and its receptors in colorectal carcinoma.雌激素及其受体在结直肠癌中的意义。
Cancer Med. 2023 Feb;12(4):4367-4379. doi: 10.1002/cam4.5242. Epub 2022 Oct 7.
9
Environmental Cadmium Exposure Promotes the Development, Progression and Chemoradioresistance of Esophageal Squamous Cell Carcinoma.环境镉暴露促进食管鳞状细胞癌的发生、发展及放化疗耐药性。
Front Cell Dev Biol. 2022 Feb 18;10:792933. doi: 10.3389/fcell.2022.792933. eCollection 2022.
10
Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action.肥胖诱导物:它们的鉴定方法及作用的分子机制。
Front Endocrinol (Lausanne). 2021 Nov 25;12:780888. doi: 10.3389/fendo.2021.780888. eCollection 2021.